Given that Ki-67 is a marker for T cell reinvigoration during checkpoint inhibitor treatment (13, 19), our monitoring suggests that the T cells functioning in both antitumor immunity and autoimmunity could not be re-activated in this patient once they had been strongly suppressed by corticosteroids. This evidence concerns the gene MKI67 and Autoimmunity.